Archive · 31 Jul 2025
Fredun Pharma's Profit Up 64% on Demand and Expansion
Fredun Pharmaceuticals, a company that makes medicines, did very well this past quarter!
They made 64% more profit than last year because more people wanted their products.
Their sales also went up, and they are expanding into the pet care market by purchasing a company.
The company plans to grow by expanding its product offerings in the future.
Fredun Pharmaceuticals' net profit for the June quarter increased by 64% to ₹7 crore.
Revenue rose 52% to ₹120 crore compared to the same period last year.
EBITDA saw a 62% increase, reaching ₹17 crore.
The company has an order book of over ₹200 crore, providing strong revenue visibility.
Fredun acquired a controlling stake in One Pet Stop, entering the pet care market.
- Who
- Fredun Pharmaceuticals Limited.
- What
- Fredun Pharmaceuticals reported a 64% increase in net profit for the June quarter.
- When
- The financial results were reported for the June quarter, published on July 31, 2025.
- Where
- Not explicitly mentioned, but the company is based in India.
- Why
- The company's growth is attributed to its growth strategy, demand for its products, and market diversification.
- Net Profit (June Quarter)
- ₹7 crore
- Net Profit YoY Growth
- 64%
- Revenue (June Quarter)
- ₹120 crore
- Revenue YoY Growth
- 52%
- EBITDA YoY Growth
- 62%
- EBITDA (June Quarter)
- ₹17 crore
- Order Book
- ₹200 crore
